Previous close | 55.30 |
Open | 58.26 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 58.26 - 58.26 |
52-week range | 48.04 - 61.12 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Barry Flannelly, Executive Vice President & General Manager US of Incyte Corp (NASDAQ:INCY), executed a sale of 19,164 shares in the company on June 12, 2024.
Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell.
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.